AI Chuck E. Cheeses, Vera Supercomputers and Investor Gravity -( $AMWL $HPE $NVDA $SMWB )

Mark Cuban’s latest thought experiment starts where most AI debates end: with a pile of empty data centers and a lot of bruised egos. Instead of forecasting doom, he wonders whether an AI bust could become the most unexpected jobs program since the mall food court. If hulking server barns morph into Chuck E. Cheese outlets and SMB hubs, Cuban argues, entrepreneurs and small businesses—which account for roughly 60% of new jobs annually—could soak up the slack.

It’s a surprisingly bullish take on a bearish scenario: even if AI demand wobbles, the physical and human capital does not evaporate; it gets repurposed. Investors used to thinking in straight lines may need to sharpen their taste for economic recycling and second acts.

Agentic AI And The Vera CPU Engine

While Cuban imagines data centers serving pizza, Los Alamos National Laboratory is quietly turning them into scientific brain trusts. Its upcoming Mission, Vision and Veritas supercomputers—codesigned with Hewlett Packard Enterprise (HPE) and powered by NVIDIA’s Vera Rubin platform—aim to unlock “agentic AI” for science, where AI agents autonomously form hypotheses, choose tools, run simulations and iterate. For NVIDIA Corporation (NVDA), Vera’s custom Olympus cores, LPDDR5 memory and high-speed fabric have already delivered roughly 7x performance on URSA agent workloads versus the Crossroads x86 supercomputer and over 3x gains on Branson Monte Carlo simulations.

LANL’s roadmap positions Mission and Vision, expected around 2027, as successors to existing Grace/Grace Hopper–based systems like Venado, extending a decade-long NVIDIA–LANL collaboration on CPU and GPU architectures. For investors, that signals that AI infrastructure isn’t just about serving chatbots; it underpins nuclear security, materials science, biomedical research and energy modeling—domains that don’t tend to disappear in the next upgrade cycle.

Behavioral Science Meets Healthcare Alpha

A recent Nature Human Behaviour–linked study surfaced in healthcare sector coverage highlights how human psychology interacts with health outcomes and policy, adding another layer to the AI narrative. While the article sits within the healthcare vertical, the implications stretch into biotech and medtech, where AI-driven experimentation increasingly relies on understanding not just molecules, but the humans who take them.

For publicly traded healthcare names i.e Amwell (AMWL), that blend of behavioral insight and data-driven experimentation reinforces a simple investor theme: AI is not a standalone story; it is a force multiplier for existing scientific and commercial moats. Companies that can connect clinical data, behavioral patterns and algorithmic modeling will likely enjoy more durable advantages than those simply “adding an LLM” to the pitch deck.

Similarweb’s Multi Seven-Figure Signal

On the commercial side of the spectrum, Similarweb Ltd. (SMWB) has secured a multi–seven figure, multi-year engagement centered on digital intelligence and data. The deal underscores how enterprise buyers are not just purchasing AI tools; they are locking in traffic analytics, competitive intelligence and web performance data that feed AI models and decision engines.

For SMWB, recurring high-ticket contracts suggest that “picks and shovels” for the digital economy—clean traffic datasets, benchmarking tools, and observability—remain valuable even as AI narratives gyrate. If Cuban’s hypothetical AI bust turns server farms into arcades, the underlying demand for knowing who is clicking, watching and buying online should remain intact.

The Investor-Magnetic Takeaway

Put Cuban’s Chuck E. Cheese scenario, LANL’s Vera-powered agentic AI, behavioral healthcare research and Similarweb’s data deals together, and a pattern emerges. The AI cycle is not a binary bet on “boom forever” versus “total collapse”; it looks more like a series of capital reallocations around computation, data and human behavior.

For investors, several themes stand out:

• AI infrastructure has deep, non-hype use cases in national security and scientific research (NVDA, HPE and partners).
• Enterprise data and analytics providers like SMWB can remain relevant across cycles, supplying the streams that AI and humans both drink from.
• Healthcare and behavioral research will increasingly intersect with AI, shaping how new therapies and policies are designed and tested.
• Even in a downside scenario, physical assets and talent tied to AI can be repurposed into new SMB-driven ecosystems, sustaining job creation and local growth.

In other words, whether the future looks more like Mission and Vision or more like a strip of neon-lit arcades, the long-term game is about owning the computation, the data, and the behavioral insight. Would you rather underwrite the pizza, the supercomputer, or the traffic map that tells both where the customers are?

The Sources

1. Mark Cuban on AI “collapsing” and data centers becoming Chuck E. Cheeses – Barchart
2. NVIDIA Vera CPU and agentic scientific AI at Los Alamos National Laboratory – NVIDIA Blog
3. Nature Human Behaviour–linked healthcare/behavior study (via Yahoo Finance Healthcare sector coverage) – Yahoo Finance Healthcare
4. Similarweb multi–seven-figure, multi-year digital intelligence deal – Yahoo Finance Markets